Skip to main content

Table 2 Impact of adjustments for estimated glomerular filtration rate (eGFR), pulse wave velocity (PWV) or C-reactive protein (CRP) on the relative contribution of circulating resistin concentrations to variations in inappropriate left ventricular mass (LVMinappr) in a community sample (n = 647)

From: Associations between circulating resistin concentrations and left ventricular mass are not accounted for by effects on aortic stiffness or renal dysfunction

Models with→aa + eGFRa + PWVa + CRP
β-coeff ±SEMp valueβ-coeff±SEMp valueβ-coeff±SEMp valueβ-coeff±SEMp value
Age−0.022 ± 0.051=0.67−0.118 ± 0.060=0.048−0.022 ± 0.055=0.69−0.034 ± 0.051=0.50
Male gender0.091 ± 0.045=0.0370.090 ± 0.044=0.0430.091 ± 0.044=0.0470.091 ± 0.045=0.042
BMI0.244 ± 0.046< 0.00010.227 ± 0.046< 0.00010.257 ± 0.049< 0.00010.216 ± 0.049< 0.0001
SBP−0.088 ± 0.043=0.0075−0.133 ± 0.043=0.0022−0.089 ± 0.046=0.0076−0.122 ± 0.043=0.0050
Log resistin0.119 ± 0.038=0.00180.130 ± 0.038=0.00060.118 ± 0.038=0.00200.149 ± 0.038=0.0001
eGFR or PWV or CRP−0.143 ± 0.053=0.00690.002 ± 0.050=0.980.012 ± 0.045=0.78
HOMA-IR0.114 ± 0.0390.00350.098 ± 0.039=0.0120.083 ± 0.037=0.00270.121 ± 0.039=0.0019
  1. β-coeff standardized β-coefficient, BMI body mass index, SBP office systolic blood pressure; HOMA-IR homeostasis model of insulin resistance. aAdditional factors included in the stepwise regression models include regular smoking, regular alcohol intake, treatment for hypertension and diabetes mellitus or an HbA1c > 6.5%